From ac03d235ad3ecac9ca85f07c93908ffad89476b8 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Wed, 17 Jan 2024 11:29:09 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Viaje a Ghana 2023.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/STOP2030___Viaje a Ghana 2023.md b/pages/STOP2030___Viaje a Ghana 2023.md index 092a960b..6e7150d3 100644 --- a/pages/STOP2030___Viaje a Ghana 2023.md +++ b/pages/STOP2030___Viaje a Ghana 2023.md @@ -30,7 +30,7 @@ date:: [[2023/12]] - Good Clinical Practice (can be GFDA or from different organization as long as not expired) - Reference lab - Samples should be run on site (Kato Katz in the schools) and others in-country (ELISA dried blood spots for [[Strongyloides]]), with a lab in Accra still to be identified. - - Communication & Social mobilization - NTD Programme/ [[GHS/RDD]]/Health Promotion/Mundo Sano + - ##### Communication & Social mobilization - NTD Programme/ [[GHS/RDD]]/Health Promotion/Mundo Sano - Frame messaging on why doing clinical trial as based on [[Trichuris trichiura]] burden – evidence for clinical trial most clear as albendazole is less effective and we have decent burden data; Reinforce messaging that will be a clinical trial, building on and using MDA architecture as much as possible - GHS to review external communications plan – Tuesday 19th - All/Mundo Sano facilitate